-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2016 to 2024.
- Arrowhead Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2023 was $64.8M.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$420M, a 337% decline from 2023.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$96.2M, a 1675% decline from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$5.42M, a 96.2% increase from 2021.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)